Client News

ViGeneron signs gene therapy strategic collaboration and option agreement with Regeneron for one inherited retinal disease target

Newron announces AGM 2022 results

InflaRx Announces Encouraging Phase III Topline Results from PANAMO Trial of Vilobelimab in Severe COVID-19 Patients

Data on the antimicrobial activity of XF-73 against bacteria within biofilms to be presented at prestigious 2022 ECCMID Congress

HepaRegeniX appoints Elias Papatheodorou as new Chairman of the Board of Directors

Adocia strengthens its cash position by 19 million euros following a real estate transaction

Atriva Therapeutics announces efficacy of its lead compound zapnometinib against Omicron

InflaRx Reports Full Year 2021 Financial and Operating Results

Heidelberg Pharma Announces Financial Figures for Fiscal Year 2021 and Provides Business Update

Atriva Therapeutics announces changes in its Management Team